We are live on ! Find out more
CLSD

Clearside Biomedical
CLSD

Delisted

CLSD was delisted on the 28th of November, 2025.

Back to rankings

47 hedge funds and large institutions have $23M invested in Clearside Biomedical in 2019 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

423% more capital invested

Capital invested by funds: $4.41M → $23M (+$18.6M)

217% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 6

38% more funds holding

Funds holding: 34 → 47 (+13)

0.05% more ownership

Funds ownership: 1.23% → 1.29% (+0.05%)

20% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 10

86% less call options, than puts

Call options by funds: $254K | Put options by funds: $1.83M

Holders
47
Holders Change
+13
Holders Change %
+38.24%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
8
Reduced
10
Closed
6
Calls
$254K
Puts
$1.83M
Net Calls
-$1.58M
Net Calls Change
-$1.58M

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$434K
2
BlackRock
BlackRock
New York
+$251K
3
Group One Trading
Group One Trading
Illinois
+$213K
4
OAM
Oxford Asset Management
United Kingdom
+$185K
5
Renaissance Technologies
Renaissance Technologies
New York
+$124K

Top Sellers

Rank Fund Capital Flow
1
S
SignatureFD
Georgia
-$176K
2
PA
Parallel Advisors
California
-$85.6K
3
Millennium Management
Millennium Management
New York
-$41.3K
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$34.3K
5
WS
Wedbush Securities
California
-$29K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
51
Morgan Stanley
New York
– -$1K -122 Closed
ASN
52
Advisory Services Network
Georgia
– -$1K -47 Closed
TWP
53
TFO Wealth Partners
Ohio
– +$126 +6 New
1 2
3

CLSD Hedge Fund Activity: Q4 2019 in Review

47 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Clearside Biomedical (CLSD) for Q4 2019, worth a combined $23M — up 423% from $4.41M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new CLSD positions and 6 closed out — a net gain of 13 holders — while 8 added to existing stakes and 10 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $434K. The largest seller was SignatureFD, cutting an estimated $176K.

  • 47 institutional investors held Clearside Biomedical (CLSD) as of Q4 2019, up from 34 in Q3 2019.
  • Funds reported $23M of Clearside Biomedical stock for Q4 2019, up 423% quarter-over-quarter.
  • 19 funds opened new Clearside Biomedical positions in Q4 2019 and 6 closed out, a net change of +13 holders.
  • The largest Clearside Biomedical buyer in Q4 2019 was Susquehanna International Group, an estimated $434K added.
  • The largest Clearside Biomedical seller in Q4 2019 was SignatureFD, an estimated $176K sold.

Based on aggregated 13F filings for Q4 2019.